Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -104.28% is 40% above its 5-year average of -173.78%, near the high end of its 5-year range (-1032.30%–-52.31%).
As of the fiscal period ended Tuesday, June 30, 2026. 6.70% above its 12-month average of -111.77%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -104.28%.
RETURN ON INVESTED CAPITAL (ROIC)
-104.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-111.77%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-141.16%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-173.78%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+6.70%
CURRENT VS 3Y AVG
+26.13%
CURRENT VS 5Y AVG
+40.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.77%
median of 763 covered companies
CURRENT VS SECTOR MEDIAN
-199.91%
vs the sector median at left
Revelation Biosciences, Inc.
Market Cap
$3.12M
Return on Invested Capital (ROIC)
-104.28%
TTM Avg
-111.77%
3Y Avg
-141.16%
5Y Avg
-173.78%
Market Cap
$3.13M
Return on Invested Capital (ROIC)
-184.27%
TTM Avg
-194.39%
3Y Avg
-144.44%
5Y Avg
-112.27%
Market Cap
$3.21M
Return on Invested Capital (ROIC)
-69.04%
TTM Avg
-69.04%
3Y Avg
-66.04%
5Y Avg
-57.92%
Market Cap
$3.23M
Return on Invested Capital (ROIC)
-75.31%
TTM Avg
-107.77%
3Y Avg
-224.28%
5Y Avg
-195.58%
Market Cap
$3.23M
Return on Invested Capital (ROIC)
-9.72%
TTM Avg
-8.51%
3Y Avg
-19.00%
5Y Avg
-22.23%
Market Cap
$2.97M
Return on Invested Capital (ROIC)
-464.86%
TTM Avg
-2260.77%
3Y Avg
-1213.54%
5Y Avg
-842.71%
Market Cap
$3.29M
Return on Invested Capital (ROIC)
-133.29%
TTM Avg
-160.18%
3Y Avg
-147.91%
5Y Avg
-122.63%
Market Cap
$3.29M
Return on Invested Capital (ROIC)
-284.81%
TTM Avg
-319.42%
3Y Avg
-246.02%
5Y Avg
-246.02%
Market Cap
$3.49M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Revelation Biosciences, Inc. (REVB) | $3.12M | -104.28% | -111.77% | -141.16% | -173.78% |
| IceCure Medical Ltd (ICCM)vs › | $3.13M | -184.27% | -194.39% | -144.44% | -112.27% |
| MBody AI Ltd. (MBAI)vs › | $3.21M | -69.04% | -69.04% | -66.04% | -57.92% |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.23M | -75.31% | -107.77% | -224.28% | -195.58% |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.23M | -9.72% | -8.51% | -19.00% | -22.23% |
| BioRestorative Therapies, Inc. (BRTX)vs › | $2.97M | -464.86% | -2260.77% | -1213.54% | -842.71% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.29M | -133.29% | -160.18% | -147.91% | -122.63% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.29M | -284.81% | -319.42% | -246.02% | -246.02% |
| Eocene Ltd. (EOCN)vs › | $3.49M | N/A | N/A | N/A | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | -45.77% | -25.13% | -754.36% | -475.60% |
ROIC
-104.3%
ROE
-106.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -104.28% |
| 2026-03-31 | -73.23% |
| 2025-12-31 | -94.41% |
| 2025-09-30 | -75.02% |
| 2025-06-30 | -211.90% |
| 2025-03-31 | -283.54% |
| 2024-12-31 | -169.38% |
| 2024-09-30 | -319.68% |
| 2024-06-30 | -835.51% |
| 2024-03-31 | -94.36% |
| 2023-12-31 | -130.22% |
| 2023-09-30 | -85.61% |
| 2023-06-30 | -52.31% |
| 2023-03-31 | -58.88% |
| 2022-12-31 | -1032.30% |
| 2022-09-30 | -606.15% |
| 2021-09-30 | -300.63% |
| 2021-06-30 | -120.96% |
| 2021-03-31 | -7.88% |
| 2020-12-31 | -4.34% |
| 2020-09-30 | -5.37% |
